BACKGROUND: Pseudoxanthoma elasticum (PXE), an autosomal recessive disorder with considerable phenotypic variability, mainly affects the eyes, skin and cardiovascular system, characterised by dystrophic mineralization of connective tissues. It is caused by mutations in the ABCC6 (ATP binding cassette family C member 6) gene, which encodes MRP6 (multidrug resistance-associated protein 6). OBJECTIVE: To investigate the mutation spectrum of ABCC6 and possible genotype-phenotype correlations. METHODS: Mutation data were collected on an international case series of 270 patients with PXE (239 probands, 31 affected family members). A denaturing high-performance liquid chromatography-based assay was developed to screen for mutations in all 31 exons, eliminating pseudogene coamplification. In 134 patients with a known phenotype and both mutations identified, genotype-phenotype correlations were assessed. RESULTS: In total, 316 mutant alleles in ABCC6, including 39 novel mutations, were identified in 239 probands. Mutations were found to cluster in exons 24 and 28, corresponding to the second nucleotide-binding fold and the last intracellular domain of the protein. Together with the recurrent R1141X and del23-29 mutations, these mutations accounted for 71.5% of the total individual mutations identified. Genotype-phenotype analysis failed to reveal a significant correlation between the types of mutations identified or their predicted effect on the expression of the protein and the age of onset and severity of the disease. CONCLUSIONS: This study emphasises the principal role of ABCC6 mutations in the pathogenesis of PXE, but the reasons for phenotypic variability remain to be explored.
BACKGROUND: Pseudoxanthoma elasticum (PXE), an autosomal recessive disorder with considerable phenotypic variability, mainly affects the eyes, skin and cardiovascular system, characterised by dystrophic mineralization of connective tissues. It is caused by mutations in the ABCC6 (ATP binding cassette family C member 6) gene, which encodes MRP6 (multidrug resistance-associated protein 6). OBJECTIVE: To investigate the mutation spectrum of ABCC6 and possible genotype-phenotype correlations. METHODS: Mutation data were collected on an international case series of 270 patients with PXE (239 probands, 31 affected family members). A denaturing high-performance liquid chromatography-based assay was developed to screen for mutations in all 31 exons, eliminating pseudogene coamplification. In 134 patients with a known phenotype and both mutations identified, genotype-phenotype correlations were assessed. RESULTS: In total, 316 mutant alleles in ABCC6, including 39 novel mutations, were identified in 239 probands. Mutations were found to cluster in exons 24 and 28, corresponding to the second nucleotide-binding fold and the last intracellular domain of the protein. Together with the recurrent R1141X and del23-29 mutations, these mutations accounted for 71.5% of the total individual mutations identified. Genotype-phenotype analysis failed to reveal a significant correlation between the types of mutations identified or their predicted effect on the expression of the protein and the age of onset and severity of the disease. CONCLUSIONS: This study emphasises the principal role of ABCC6 mutations in the pathogenesis of PXE, but the reasons for phenotypic variability remain to be explored.
Authors: L Cai; A Lumsden; U P Guenther; S A Neldner; S Zäch; H Knoblauch; R Ramesar; D Hohl; D F Callen; K H Neldner; K Lindpaintner; R I Richards; B Struk Journal: J Mol Med (Berl) Date: 2001-09 Impact factor: 4.599
Authors: A A Bergen; A S Plomp; E J Schuurman; S Terry; M Breuning; H Dauwerse; J Swart; M Kool; S van Soest; F Baas; J B ten Brink; P T de Jong Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: I Meloni; P Rubegni; G De Aloe; M Bruttini; E Pianigiani; R Cusano; M Seri; S Mondillo; A Federico; A M Bardelli; L Andreassi; M Fimiani; A Renieri Journal: Hum Mutat Date: 2001 Impact factor: 4.878
Authors: Attila Iliás; Zsolt Urbán; Thomas L Seidl; Olivier Le Saux; Emese Sinkó; Charles D Boyd; Balázs Sarkadi; András Váradi Journal: J Biol Chem Date: 2002-03-05 Impact factor: 5.157
Authors: O Le Saux; K Beck; C Sachsinger; C Silvestri; C Treiber; H H Göring; E W Johnson; A De Paepe; F M Pope; I Pasquali-Ronchetti; L Bercovitch; A S Marais; D L Viljoen; S F Terry; C D Boyd Journal: Am J Hum Genet Date: 2001-08-31 Impact factor: 11.025
Authors: O Le Saux; Z Urban; C Tschuch; K Csiszar; B Bacchelli; D Quaglino; I Pasquali-Ronchetti; F M Pope; A Richards; S Terry; L Bercovitch; A de Paepe; C D Boyd Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: M H Tan; O M Vanakker; H V Tran; A G Robson; J E Lai-Cheong; R Groves; G E Holder; A T Moore Journal: Eye (Lond) Date: 2012-01-20 Impact factor: 3.775
Authors: Qiaoli Li; Leon J Schurgers; Ann C M Smith; Maria Tsokos; Jouni Uitto; Edward W Cowen Journal: Am J Pathol Date: 2008-12-30 Impact factor: 4.307
Authors: Qiaoli Li; Dorothy K Grange; Nicole L Armstrong; Alison J Whelan; Maria Y Hurley; Mark A Rishavy; Kevin W Hallgren; Kathleen L Berkner; Leon J Schurgers; Qiujie Jiang; Jouni Uitto Journal: J Invest Dermatol Date: 2008-09-18 Impact factor: 8.551